|
TRAIL binding
|
GO_0045569 |
[Binding to TRAIL (TNF-related apoptosis inducing ligand), a member of the tumor necrosis factor ligand family that rapidly induces apoptosis in a variety of transformed cell lines.] |
|
obsolete regulation of TRAIL receptor 1 biosynthetic process
|
GO_0045561 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL (TNF-related apoptosis inducing ligand) receptor 1.] |
|
obsolete regulation of TRAIL receptor 2 biosynthetic process
|
GO_0045562 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL (TNF-related apoptosis inducing ligand) receptor 2.] |
|
fourth ventricle development
|
GO_0021592 |
[The process whose specific outcome is the progression of the fourth ventricle over time, from its formation to the mature structure. The fourth ventricle is an irregularly shaped cavity in the rhombencephalon, between the medulla oblongata, the pons, and the isthmus in front, and the cerebellum behind. It is continuous with the central canal of the cord below and with the cerebral aqueduct above, and through its lateral and median apertures it communicates with the subarachnoid space.] |
|
obsolete negative regulation of TRAIL receptor biosynthetic process
|
GO_0045563 |
[OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the TRAIL (TNF-related apoptosis inducing ligand) receptor.] |
|
K63-linked polyubiquitin modification-dependent protein binding
|
GO_0070530 |
[Binding to a protein upon poly-ubiquitination formed by linkages between lysine residues at position 63 in the target protein.] |
|
obsolete positive regulation of TRAIL receptor biosynthetic process
|
GO_0045564 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the TRAIL (TNF-related apoptosis inducing ligand) receptor.] |
|
BRCA1-A complex
|
GO_0070531 |
[A protein complex that contains the BRCA1-BARD1 heterodimer, RAP80/UIMC1, BRCC3/BRCC36, BRE/BRCC45, FAM175A/CCDC98/Abraxas and MERIT40/NBA1, and specifically recognizes and binds K63-linked polyubiquitin chains present on histone H2A and H2AX at DNA damage sites.] |
|
abducens nerve morphogenesis
|
GO_0021598 |
[The process in which the anatomical structure of the abducens nerve is generated and organized. The motor function of the abducens nerve is to contract the lateral rectus which results in abduction of the eye.] |
|
obsolete negative regulation of TRAIL receptor 1 biosynthetic process
|
GO_0045565 |
[OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL (TNF-related apoptosis inducing ligand) receptor 1.] |
|
BRCA1-B complex
|
GO_0070532 |
[A protein complex that contains the BRCA1-BARD1 heterodimer, BACH1 and TopBP1, and binds to DNA during S phase at DNA damage sites.] |
|
abducens nerve formation
|
GO_0021599 |
[The process that gives rise to the abducens nerve. This process pertains to the initial formation of a structure from unspecified parts. The motor function of the abducens nerve is to contract the lateral rectus which results in abduction of the eye.] |
|
obsolete positive regulation of TRAIL receptor 1 biosynthetic process
|
GO_0045566 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL (TNF-related apoptosis inducing ligand) receptor 1.] |
|
BRCA1-C complex
|
GO_0070533 |
[A protein complex that contains the BRCA1-BARD1 heterodimer, CtIP and Mre11/Rad50/NBS1 (M/R/N) complex, and binds to DNA at DNA damage sites. BRCA1-C binding ta damaged DNA is required for DNA damage-induced Chk1 phosphorylation and the G2/M transition checkpoint.] |
|
obsolete negative regulation of TRAIL receptor 2 biosynthetic process
|
GO_0045567 |
[OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL (TNF-related apoptosis inducing ligand) receptor 2.] |
|
protein K63-linked ubiquitination
|
GO_0070534 |
[A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation, but is involved in several pathways, notably as a signal to promote error-free DNA postreplication repair.] |
|
central nervous system structural organization
|
GO_0021597 |
[The process that contributes to the act of creating the structural organization of the central nervous system structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain, spinal cord and spinal nerves. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.] |
|
obsolete positive regulation of TRAIL receptor 2 biosynthetic process
|
GO_0045568 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL (TNF-related apoptosis inducing ligand) receptor 2.] |
|
obsolete histone H2A K63-linked ubiquitination
|
GO_0070535 |
[OBSOLETE. A histone ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a lysine residue in histone H2A or the variant H2AX.] |
|
protein K63-linked deubiquitination
|
GO_0070536 |
[A protein deubiquitination process in which a K63-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is removed from a protein.] |